Connect with us

Media OutReach

Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform

Published

on

  • Health2Sync’s SugarGenie app is experiencing rapid growth and positive reception in South Korea.
  • The platform is being utilized in both hospital settings and through government programs. Health2Sync has partnered with Sanofi for hospital rollouts and integrated its solution with South Korea’s Primary Health Care Chronic Disease Management Program, reaching over 100 healthcare institutions by December 2024 for diabetes, hypertension, and obesity care.
  • Healthcare professionals praise the app for improving patient care: SugarGenie enhances the ability to monitor patient data, provide personalized guidance, and effectively manage chronic conditions like diabetes.

TAIPEI, TAIWAN – Media OutReach Newswire – 18 February 2025 – Health2Sync, a leading provider of digital therapeutics solutions for chronic diseases, announced today that it is experiencing significant growth and positive feedback from healthcare professionals in South Korea. Since launching its app, SugarGenie, in January 2024, the company has witnessed a surge in adoption among healthcare institutions. The company’s solution offers data integration, visualization, and personal insights to improve patient care quality and streamline clinical workflows.

Health2Sync’s “SugarGenie” app enables users to view their blood glucose and other lifestyle data in one place.

While Health2Sync started rolling out its integrated diabetes management solution with Sanofi in hospitals and clinics in South Korea, the company also tapped into the local government’s Primary Health Care Chronic Disease Management Program, which empowers doctors to engage with patients directly. As of December 2024, over 100 healthcare institutions have implemented Health2Sync’s Patient Management Platform to enhance the care of patients with diabetes, hypertension, and obesity.

“Health2Sync’s solution has been instrumental in improving the quality of treatment for our patients,” said Prof. SunJoon Moon, Gangbuk Samsung Hospital. “We can easily monitor patients’ data in the hospital and provide personalized guidance, significantly enhancing our ability to manage diabetes patients effectively.”

The SugarGenie app captures data from various devices from renowned chronic disease management brands, including Abbott, Sanofi, Omron, Roche, and i-SENS. It allows automatic data synchronization from Continuous Glucose Monitors (CGMs), Blood Glucose Meters (BGMs), insulin caps such as SoloSmart™, and blood pressure monitors.

Besides the vitals, other lifestyle data such as diet, medication, exercise, and sleep play crucial roles in chronic disease management. SugarGenie seamlessly connects with the iPhone’s Health App and the Health Connect (such as Samsung Health) from Android phones. With patient consent, this comprehensive data is automatically transmitted to the platform, empowering healthcare providers with valuable insights for informed decision-making.

To help patients better self-manage diabetes, the SugarGenie App offers automated engagement programs prescribed by doctors to deliver personalized education, reminders, and insights directly to patients. This innovative approach alleviates the burden on healthcare resources and enhances patient engagement.

“This platform is very useful for managing patients registered in the government’s ‘Primary Health Care Chronic Disease Management Program.’ At our clinic, we monitor patients’ self-measured data such as blood sugar and blood pressure and send educational materials and guides to patients’ apps through the two-way messaging function,” said Dr. Kun-Ho Yoon, Dr. Yoon IM Clinic, former Chairman of the board, Korean Diabetes Association).

Health2Sync has integrated with Eghis Healthcare, a leading Electronic Medical Record (EMR) company serving over 6,000 clinics in South Korea, to streamline clinical workflows. This synchronization enhances the efficiency and quality of chronic disease management by smoothly embedding Health2Sync’s data with existing clinical systems.

“We are thrilled by the rapid adoption of Health2Sync’s solutions in South Korea,” said Ed Deng, Co-founder and CEO of Health2Sync. “Our commitment to improving patient outcomes through innovative digital therapeutics is unwavering, and we look forward to continuing to expand our reach and impact in this dynamic market.”Hashtag: #health2sync #diabetesmanagement #digitaltherapeutis #digitalhealth




The issuer is solely responsible for the content of this announcement.

About Health2Sync

Founded in 2013, Health2Sync offers digital solutions to help people with chronic diseases, pre-diabetes, or weight concerns to manage their health. The company’s achievements include being the first approved digital therapeutics in Taiwan for their insulin dosage titration software, Insultrate, which they co-developed with Sanofi. The company has also received the “NEXT BIG” Startup title from the Taiwan National Development Council.

For more information, please visit

Advertisement

Media OutReach

From PolyU Research to Geneva Global Debut: GOOD Vision oka³y! ™ Redefines Precision in Freeform Orthokeratology

Published

on

GENEVA, SWITZERLAND – Media OutReach Newswire – 9 March 2026 – GOOD Vision Technologies Co., Limited, a pioneer in ophthalmic optics and diagnostics, today announced the global debut of oka³y!™, a first-of-its-kind “3A” Freeform Orthokeratology (Ortho-K) solution. Unveiled at the 51st International Exhibition of Inventions in Geneva, the technology solves the industry’s most persistent hurdles by leveraging proprietary AI and freeform optics: AI-guided fitting, Astigmatic precision, and Asymmetric cornea alignment.

Beyond Traditional Toric Lenses: The Future of Freeform Orthokeratology

With myopia expected to affect 50% of the world’s population by 2050, demand for effective management is high. While Ortho-K is a highly effective strategy, traditional symmetric and spherical/ toric designs often underestimate corneal shape complexity, causing lens decentration and poor visual outcomes.

The oka³y!™ freeform technology, incorporating the company’s proprietary FAST-360 and CORe Technology, surpasses traditional lens design. AI-based FAST-360 reconstructs missing corneal data for faster scans, while CORe ensures precise alignment with the visual axis, leading to 3.1 times greater stability.

Precision Myopia Correction and Control for High Astigmatism and Asymmetric Corneas

For optometrists and clinic owners, oka³y!™’s key benefit is improving workflow by automating complex mathematics, cutting chair time by 64%. This boosts myopia management capacity without extra staff or lengthy training. “As a registered optometrist in Hong Kong and a researcher in one of the world’s leading optometric institutes, I witnessed a growing gap between the number of patients seeking Ortho-K and the limited range of conventional products available to treat them,” says Dr. Kin Ho Chan, Ken, the lead inventor of oka³y!™. “By focusing on the ‘3A’: AI-guided, Astigmatism, and Asymmetry, and working alongside The Hong Kong Polytechnic University (Poly U), we have developed a design that not only delivers superior vision but also enhances safety by reducing corneal staining. We are turning a frustrating, manual trial-and-error process into a predictable one-click adjustment.”

From Niche Specialty to Global Enterprise: Scaling the Future of Eye Care

As myopia rates reach epidemic levels, GOOD Vision partners with PolyU, harnessing its research strengths and support from its startup ecosystem PolyVentures, to redefine primary eye care by transforming a niche specialty into a scalable global enterprise. By replacing manual OK lens design with oka³y!™, the company has created a technology bridging clinical complexity and scalability. This transition enables practitioners to manage myopia, high astigmatism, and asymmetrical cases precisely, removing barriers to modern refractive error management.

“By embedding and automating the complex mathematics of lens design, we provide clinicians with the tools to treat ‘difficult’ patients who were previously considered unsuitable for Ortho-K,” added Professor Chea-su Kee, Founder of GOOD Vision. “This is about elevating the global standard of care and ensuring that precision myopia management is accessible to the next generation on a global scale.”

Experience the Future of Myopia Control

GOOD Vision invites investors, distributors, and practitioners to a live demonstration of the oka³y!™ at the International Exhibition of Inventions Geneva:

  • Location: PolyU Delegation Booth, Hall 2, Palexpo, CP 112, Route François-Peyrot 30, 1218 Le Grand-Saconnex, Geneva, Switzerland
  • Dates: 11–15 March 2026

Hashtag: #GOODVision

The issuer is solely responsible for the content of this announcement.

About GOOD Vision Technologies Co., Limited

GOOD Vision, a Hong Kong-based startup nurtured by PolyU, is dedicated to advancing the field of corneal reshaping technologies. With a focus on innovation, efficiency, and affordability, the company develops innovative solutions to empower eye practitioners and enhance the quality of eye care worldwide.

For additional details about GOOD Vision and their innovative offerings, please visit

Continue Reading

Media OutReach

Tech Innovator Acquires Nexxus Building Trivium to Oversee Asset Management

Published

on

Central Landmark Set for Revitalization with International Expertise

HONG KONG SAR – Media OutReach Newswire – 9 March 2026 – In a vote of confidence in Hong Kong’s vibrant and enduring business environment, Nexxus Building, a landmark Grade‑A commercial property in Central’s prestigious CBD, has been acquired by a leading figure in the technology sector. Trivium Asset Management (“Trivium”), an Asian real estate investment and asset management firm, has been appointed as Nexxus Building’s Asset Manager (“AMC” or Asset Management Company), taking charge of the asset’s comprehensive management and operations.

Under new ownership, Nexxus Building is set to undergo a forward‑looking transformation integrating next‑generation technologies with world‑class professional management. The revitalization aims to redefine the building’s market positioning, enhance its tenant experience, and reinforce its status as an iconic and premier Grade‑A property in the heart of Hong Kong’s CBD.

Leveraging Trivium’s extensive expertise, the enhancement programme will incorporate smart‑building management systems and sustainability‑driven upgrades designed to meet the evolving needs of global tenants. The reimagined Nexxus Building aims to attract financial institutions, fintech platforms, and technology enterprises, reaffirming Central’s position as Asia’s dynamic financial and innovation hub.

Mr. Wilfred Ma, Managing Partner of Trivium Asset Management, said, “Trivium is honored to be entrusted with the role of Asset Manager (“AMC” or Asset Management Company) for Nexxus Building, one of Hong Kong’s most iconic commercial landmarks. Drawing on our track record in real estate investment and operations across Hong Kong and Japan, we are committed to implementing forward‑thinking strategies that enhance tenant value, optimize building performance, and unlock Nexxus Building’s full potential as a commercial anchor in the city’s core.”

Originally built in 1962 as the former headquarters of Hang Seng Bank, Nexxus Building has been a witness to Hong Kong’s rise as a global financial centre. Following a major renovation in 2008 and the addition of a direct footbridge to IFC and the Airport Express in 2020, the building continues to host multinational corporations, leading financial institutions and professional services firms, and premium retail tenants – including the iconic Hong Kong Bankers Club – reinforcing its status as one of Central’s most distinguished Grade‑A office towers.

Hashtag: #TriviumAssetManagement

The issuer is solely responsible for the content of this announcement.

About Trivium Asset Management

Founded in 2022, Trivium Asset Management is a Hong Kong‑based real estate investment and asset management firm overseeing assets valued at over US$900 million across Asia. Trivium serves institutional investors, financial institutions, and family offices through integrated investment and asset management, value‑creation strategies, and technology integration. The firm’s mission is to maximize long‑term value and promote sustainable growth for clients and communities alike.

Continue Reading

Media OutReach

HOFA Announces the Second Edition of the Digital Art Awards, in Collaboration with Exhibition Partner PhillipsX in Hong Kong, proudly backed by Lightyear

Published

on

HONG KONG SAR – Media OutReach Newswire – 9 March 2026 – Celebrating a new generation of digital artists working across generative systems, AI, immersive media and experimental formats, with winners selected by a panel of leading experts and exhibited at Phillips’ Asia headquarters in the West Kowloon Cultural District during Hong Kong Art Basel Week 2026.

Refik Anadol, ‘Sense of Healing’, 2023, AI Data Sculpture (Courtesy of the Artist)

The awards ceremony will take place on 24 March 2026, featuring the four key categories of Still Image, Moving Image, Innovation and Experiential and followed by a private sale exhibition hosted by Phillips in Hong Kong, from 25–28 March 2026.

As a highlight of Hong Kong’s spring art calendar, the awards celebrate the growing cultural significance of digital art and spotlights the visionary artists redefining visual culture through cutting-edge technologies.

Thirty two international finalists will be selected for their work pushing the boundaries of digital creativity. Each of the four category winners will receive a $10,000 USDC commission towards a new artwork.

The thirty two finalists include several prominent figures in digital and generative art, such as Erick Calderon (Snowfro) Founder of Art Blocks, Botto, Sarah Meyohas, William Mapan, Sasha Stiles and Mario Klingemann – underscoring the calibre of talent the awards are already attracting with over two hundred applications across more than fifty countries.

Refik Anadol is nominated for the Honorary Career Award for Sense of Healing, an AI Data Sculpture that emerges from Refik Anadol Studio’s long-term research into creating meditative art based on neurological data.

Finalists and winners will be selected by a panel of leading experts in art, hospitality and technology, including Irini Mirena Papadimitriou, Exhibitions Director at Diriyah Art Futures, Thomas Heyne, Co-Founder and CEO at Scorpios, Dorothy di Stefano, Art Curator and Creative Strategist at Molten Immersive Art, Danielle So, Hong Kong Head of Auction, Modern & Contemporary Art, Phillips, Sebastien Borget, Co-Founder & Global of The Sandbox, SANDchain, President of Blockchain Game Alliance and Co-Founder of Artverse, Jean-Michel Pailhon, Co-Founder and Chief Investment Officer at Grailcapital, Simonida Pavicevic, Co-Founder and Curator at HOFA, Justin Gilanyi, Founder of WhereArt.Works and Curator at SILK, and Matt Zhang, Founder and Managing Partner at Hivemind Capital.

The Digital Art Awards are proudly backed by Lightyear, a subsidiary of Hivemind Digital Group. A full-stack digital culture partner, Lightyear provides infrastructure, liquidity and market expertise, and hands-on delivery for digital ownership and engagement across physical and digital experiences. Lightyear is committed to championing artists and organizations pushing the boundaries of digital culture.

Hashtag: #HOFA #PhillipsX

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending